Basit öğe kaydını göster

dc.contributor.authorAlpsar, Dilek
dc.contributor.authorCagatay, Atahan
dc.contributor.authorAkguel, Baki
dc.contributor.authorBozkaya, Emel
dc.contributor.authorAgacfidan, Ali
dc.contributor.authorLuebke, Nadine
dc.contributor.authorVerheyen, Jens
dc.contributor.authorEraksoy, Haluk
dc.contributor.authorKaiser, Rolf
dc.date.accessioned2021-03-04T11:28:38Z
dc.date.available2021-03-04T11:28:38Z
dc.date.issued2013
dc.identifier.citationAlpsar D., Agacfidan A., Luebke N., Verheyen J., Eraksoy H., Cagatay A., Bozkaya E., Kaiser R., Akguel B., "Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul", MEDICAL MICROBIOLOGY AND IMMUNOLOGY, cilt.202, sa.3, ss.251-255, 2013
dc.identifier.issn0300-8584
dc.identifier.otherav_7288b8c3-cb69-4d4c-a0ac-d124635cfa43
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/78837
dc.identifier.urihttps://doi.org/10.1007/s00430-012-0285-7
dc.description.abstractIn Turkey, the first HIV/AIDS case was reported in 1985. Since then the number of persons with HIV infection has increased, HIV is getting a public health problem. The aim of this study was to determine HIV-1 subtype diversity, drug resistance and gag cleavage site mutations among 20 HIV-infected men having sex with men from Istanbul, Turkey. The most prevalent subtype was found to be subtype B (50 %), but also the non-B subtypes A1, C and CRF02_AG, CRF03_AB and CRF06_cpx were found. Resistance-associated mutations were found in 6 patients (30 %) with 2/6 patients being therapy-experienced and 4/6 therapy-na < ve at the time-point of analysis. In these patients, the nucleoside reverse transcriptase inhibitor (NRTI)-associated resistance mutations M41L, T215C, V75I, T69N, the non-NRTI associated mutations V106I, E138A, K103N and the protease inhibitor associated mutations Q58E and V82I were detected. Two virus strains also presented Gag cleavage site mutations. With increasing numbers of HIV-infected Turkish patients that require anti-retroviral treatment, HIV-1 drug-resistance testing is strongly recommended in order to choose the most active drug combination for therapy to achieve better clinical outcomes.
dc.language.isoeng
dc.subjectMikrobiyoloji
dc.subjectTemel Bilimler
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectYaşam Bilimleri
dc.titleMolecular epidemiology of HIV in a cohort of men having sex with men from Istanbul
dc.typeMakale
dc.relation.journalMEDICAL MICROBIOLOGY AND IMMUNOLOGY
dc.contributor.departmentUniversity of Cologne , ,
dc.identifier.volume202
dc.identifier.issue3
dc.identifier.startpage251
dc.identifier.endpage255
dc.contributor.firstauthorID40336


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster